Position in LGND
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$15,011,283
+$6,244,487 QoQ
Shares Held
75,188
+62.2% QoQ
Ownership
0.375%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in LGND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026SEI INVESTMENTS CO holds $1,293,253,921 across 195 Biotechnology names. LGND ranks #14 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
1,395,794 | $228,240,234 | |
| 2 | ARGX |
Argenx SE
|
286,966 | $209,556,920 | |
| 3 | ASND |
Ascendis Pharma A/S
|
351,146 | $80,317,623 | |
| 4 | EXEL |
Exelixis, Inc.
|
1,629,670 | $69,896,545 | |
| 5 | INCY |
Incyte Corp
|
714,558 | $67,254,197 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
133,226 | $59,490,737 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
75,000 | $57,947,999 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
100,315 | $33,191,223 |
All Filings in LGND
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $15,011,283 | 75,188 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $8,766,796 | 46,368 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $4,857,886 | 27,424 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $2,434,115 | 21,412 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,142,436 | 20,377 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $2,944,696 | 27,482 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $2,682,911 | 26,805 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $4,049,955 | 48,065 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $2,619,977 | 35,841 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $789,690 | 11,057 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $445,684 | 7,438 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $519,696 | 7,208 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $400,901 | 5,450 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $323,779 | 4,847 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $263,432 | 4,904 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $154,895 | 2,783 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $183,576 | 2,616 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,277,209 | 13,255 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,328,710 | 15,288 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $400,771 | 4,897 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $596,484 | 6,272 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $3,625,735 | 58,442 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $3,515,004 | 59,112 | Shares | Defined | 2020-12-04 | |
| 2020-06-30 | $3,229,972 | 46,291 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $1,729,173 | 38,117 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||